BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31343851)

  • 1. Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears.
    Nakra T; Nambirajan A; Guleria P; Phulware RH; Jain D
    Cancer Cytopathol; 2019 Aug; 127(8):539-548. PubMed ID: 31343851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: Validity and reliability with cutoff value.
    Abe H; Takase Y; Sadashima E; Fukumitsu C; Murata K; Ito T; Kawahara A; Naito Y; Akiba J
    Cancer Cytopathol; 2019 Sep; 127(9):598-605. PubMed ID: 31436913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple marker composed of p16, CD56, and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens.
    Švajdler M; Mezencev R; Šašková B; Ondič O; Mukenšnábl P; Michal M
    Hum Pathol; 2019 Mar; 85():58-64. PubMed ID: 30385371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulinoma-Associated Protein 1 Immunostain: A Diagnostic Tool for Pulmonary Small Cell Carcinoma in Cytology.
    Rodriguez EF; Chowsilpa S; Maleki Z
    Acta Cytol; 2018; 62(5-6):333-338. PubMed ID: 29936498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
    Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
    Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.
    Hou T; Gan Q; Joseph CT; Sun X; Gong Y
    Cancer Cytopathol; 2020 Oct; 128(10):725-732. PubMed ID: 32573984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
    Doxtader EE; Mukhopadhyay S
    Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of INSM1 and hASH1 as additional markers in lung cytology samples of high-grade neuroendocrine carcinoma with indeterminate neuroendocrine differentiation.
    Rothrock AT; Stewart J; Li F; Racila E; Amin K
    Diagn Cytopathol; 2022 May; 50(5):230-234. PubMed ID: 35147301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.
    Mukhopadhyay S; Dermawan JK; Lanigan CP; Farver CF
    Mod Pathol; 2019 Jan; 32(1):100-109. PubMed ID: 30154579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
    Chen JF; Yang C; Sun Y; Cao D
    Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens.
    Viswanathan K; Siddiqui MT; Borczuk AC
    J Am Soc Cytopathol; 2019; 8(6):299-308. PubMed ID: 31345782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of insulinoma-associated protein 1 in non-small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors.
    Wang M; Abi-Raad R; Baldassarri R; Adeniran AJ; Cai G
    Hum Pathol; 2021 Sep; 115():104-111. PubMed ID: 34216697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
    Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
    Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death-ligand 1 immunoexpression in matched biopsy and liquid-based cytology samples of advanced stage non-small cell lung carcinomas.
    Jain D; Sukumar S; Mohan A; Iyer VK
    Cytopathology; 2018 Dec; 29(6):550-557. PubMed ID: 29938855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma.
    Tsai HK; Hornick JL; Vivero M
    Mod Pathol; 2020 Aug; 33(8):1571-1580. PubMed ID: 32203089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
    Seijnhaeve E; Galant C; Van Bockstal MR
    Int J Surg Pathol; 2021 Aug; 29(5):496-502. PubMed ID: 33426999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
    Zou Q; Zhang L; Cheng Z; Guo X; Cao D
    Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma.
    Yuan C; Jiao F; Zhai C; Zhang J; Wang S; Zhu L
    Laryngoscope; 2021 Oct; 131(10):E2662-E2668. PubMed ID: 33847383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
    Zheng G; Ettinger DS; Maleki Z
    Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.